Highlights Solara Active Pharma Sciences Limited

Equities

SOLARA

INE624Z01016

Market Closed - NSE India S.E. Other stock markets 05:13:53 13/05/2024 pm IST			5-day change	1st Jan Change
522 ^INR	+6.03%		-5.70%	+44.55%

10/05	Solara Active Pharma to Raise 4.50 Billion Via Rights Issue	MT
08/04	Solara Active Pharma Sciences Limited Approves Appointment of Mohan Muthunarayanan as an Executive Director	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Solara Active Pharma Gets Board Nod to Sell 100% Stake in SeQuent Penems	26/03	MT
An undisclosed buyer agreed to acquire SeQuent Penems Private Limited from Solara Active Pharma Sciences Limited.	25/03	CI
Solara Active Pharma Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02	CI
Solara Active Pharma Sciences Widens Consolidated Loss in Fiscal Q2	14/11	MT
Solara Active Pharma Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	14/11	CI
Solara Active Pharma Sciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/23/14	CI
Solara Active Pharma's Tamil Nadu Plant in India Clears US FDA Inspection	07/23/07	MT
Solara Active Pharma Sciences Limited Reports Earnings Results for the Full Year Ended March 31, 2023	12/23/12	CI
Solara Active Pharma Sciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	12/23/12	CI
Solara Active Pharma Sciences Gets No Observations from US FDA's India Plant Inspection	30/23/30	MT
USFDA concludes inspection at Solara's Visakhapatnam facility with Zero 483 inspectional observations	30/23/30	CI
WHO Completes Prequalification Inspection of Solara's API Facility in Tamil Nadu, India	27/23/27	MT
Solara Active Pharma Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	25/23/25	CI
Solara Active Pharma Sciences : Disclosure under SEBI Takeover Regulations	30/22/30	PU
Solara Active Pharma Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	09/22/09	CI
Solara Active Pharma's Vishakhapatnam Unit Gets European Approval to Manufacture Ibuprofen	01/22/01	MT
Solara Active Pharma Sciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	04/22/04	CI
Solara Active Pharma Sciences : Disclosure under SEBI Takeover Regulations	02/22/02	PU
Karuna Business Solutions LLP agreed to acquire an additional 4.24% stake in Solara Active Pharma Sciences Limited from Arun Kumar Pillai for approximately INR 660 million.	20/22/20	CI
Solara Active Pharma Sciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	29/22/29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Solara Active Pharma Sciences Limited

Equities

SOLARA

INE624Z01016

Highlights

Filters